Virbagen Omega Европска Унија - Немачки - EMA (European Medicines Agency)

virbagen omega

virbac s.a. - rekombinantes omega-interferon feline herkunft - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. bei mit fiv infizierten katzen war die mortalität gering (5%) und wurde durch die behandlung nicht beeinflusst.

Versifel FeLV Injektionssuspension Белгија - Немачки - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

versifel felv injektionssuspension

zoetis belgium - feline leukämie-virus (felv) - injektionssuspension - feline leukämie-virus (felv) - feline leukaemia virus - katze